Canonic

Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) released its financial results for the first quarter period ending March 31, 2023, revealing revenues of $641,000, an increase of 170% compared to $237,000 in the same period the previous year. The revenue increase was primarily due to revenues recognized per...

Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) Q3 2022 revenues were $466,000, a 208% increase in comparison to $151,000 in the same period of the previous year and were primarily due to revenues recognized per the collaboration agreement of Evogene's subsidiary AgPlenus with Corteva. Q3 2022...

Medical-grade cannabis developer Canonic Ltd., and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN), announced that professor Itamar Grotto will be joining its board of directors. Grotto, former associate director general at the Israeli ministry of health, was responsible for the...

Computational biology company Evogene Ltd. (NASDAQ: EVGN)  will release its financial results for the full year and fourth quarter of 2021 on March 10, 2022. On the day of the announcement, the company's management will host a conference call to discuss the results at 09:00 a.m. EST....

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), the parent company of medical cannabis-focused Canonic, reported its financial results Wednesday for the first nine months and third quarter of 2021. The Israel-based company maintained a strong financial position for its activities with $61.6...

Evogene Ltd.'s (NASDAQ: EVGN) (TASE: EVGN) wholly-owned subsidiary focused on developing medical cannabis products, Canonic Ltd., announced the full commercial launch of its first two medical cannabis inflorescence products, known as G200 and G150. The Israel-based company said Tuesday that the...

Canonic Ltd, a company focused on the development of medical cannabis products and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today the pre-launch of its first-generation medical cannabis inflorescence products, reported PRNewswire. Canonic is a subsidiary of...

Cannbit Ltd. and Canonic Ltd. have teamed up to develop new cannabis products. Tikun Olam-Cannbit Ltd. (TASE: TKUNT) confirmed Wednesday a collaboration between its subsidiary and Evogene Ltd.'s (NASDAQ: EVGN) (TASE: EVGN) Canonic Ltd. Under the deal, Cannbit will provide clinical data...

Harborside Generates $19.6M In Q3, Expects To 'Ramp Up' Production Capacities In 2021 Harborside Inc. (CSE: HBOR) (OCTQX: HBORF) beat its third-quarter projections generating roughly $19.6 million in gross revenue. That's up by 21.2% sequentially and 42.9% year-over-year. Wholesale...

Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN.TA), an Israeli biotech connected to the cannabis industry through its subsidiary Canonic Ltd., released fourth-quarter and full-year 2019 financial results Wednesday. Evogene posted quarterly revenue of $100,000 versus $600,000 in the prior year period. For...

It's not unusual these days to see agri-tech and biotech stocks jumping on the cannabis bandwagon to capitalize on the opportunity presented by the geographically expanding legalization of pot. What Happened Israeli biotech Evogene Ltd (NASDAQ: EVGN), which is engaged in research and...